14th Workshop, Barcelona: “Mechanisms for the Implementation of the Clinical Added-Value (Relative Effectiveness) of Orphan Drugs, CAVOD”

14th Workshop of the Eurordis Round Table of Companies

EURORDIS - ERNST & YOUNG

“Mechanisms for the Implementation of the Clinical Added-Value (Relative Effectiveness) of Orphan Drugs, CAVOD”

 

May 27th, 2011

Barcelona, Spain

ertc 14th workshopJointly organised by EURORDIS and ERNST & YOUNG, this workshop was the final meeting of ERNST & YOUNG's Feasibility Study on CAVOD in the framework of the European Commission Tender. A high number of participants gathered to discuss the preliminary results of the work performed by ERNST & YOUNG. Enormous progress was achieved towards shaping the future of the CAVOD mechanism and a consensus reached on common proposals for a feasible assessment mechanism.

 

Participants: 82

Key feature: co-organised with Ernst & Young

Programme

Concept Paper

Proceedings

For ERTC Members only, this document is password protected. If you want to become a member, find out more here or contact Anne-Mary Bodin, Operations Assistant.

 

 
 
A voz das pessoas com doenças raras na EuropaEURORDIS A voz internacional das pessoas com doenças raras, Rare Diseases InternacionalRare Disease International Reúne doentes, famílias e especialistas para partilhar experiências num fórum multilinguístico. RareConnect O programa Rare Barometer é uma iniciativa da EURORDIS para a realização de inquéritos para transformar a experiência das pessoas com doenças raras em números e factos que podem ser partilhados com os responsáveis pela tomada de decisões.Rare Barometer An international awareness raising campaign taking place on the last day of February each year, Rare Disease Day is a EURORDIS initiativeRare Disease Day Adira ao maior encontro europeu das partes interessadas no âmbito das doenças raras na Conferência Bienal Europeia sobre Doenças Raras e Produtos Órfãos. A ECRD é uma iniciativa da EURORDISEuropean Conference on Rare Diseases